Language is not available For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

The measures in the areas of licensing and pricing policies would also be complemented by appropriate fiscal policy measures designed to progressively reduce import and excise duties to the minimum possible levels and to ensure that the cumulative incidence of duty on the bulk drugs is higher than that on the inputs and drug intermediates. Duty rationalization is intended to encourage cost efficient production of bulk drugs and of high quality formulations.

• औषधि नीति 1986
• Part II – Objectives
• Part III – Rational Use of Drugs
• Part IV-Quality Control
• Part V – Pricing
• Part VI – Licensing
• Part VII – Duty Rationalization
• Part VIII – Co-Ordination Between Health and Industry Ministries
• Part IX – Review
• Annexure I(Refer to Paragraph 6.1)
• Annexure – II (Refer to Paragraph 6.3)
• Annexure – III (Refer to Paragraph 6.8)